Carlsbad Newswire

Comprehensive Real-Time News Feed for Carlsbad, CA.

Results 1 - 20 of 108 for "u:americanbankingnews.com" in Carlsbad, CA

  1. NTN Buzztime Inc. (NTN) Rating Lowered to Sell at Zacks Investment ResearchRead the original story w/Photo

    Friday Aug 26 | AmericanBankingNews.com

    According to Zacks, "NTN Buzztime, Inc.is a leading developer, publisher and distributor of interactive entertainment for massive audiences on numerous consumer platforms. Millions of people are exposed to the Buzztime Network every month in restaurants, sports bars and pubs throughout the U.S., Canada and the UK.

    Comment?

  2. Analysts' Downgrades for August, 26thRead the original story w/Photo

    Friday Aug 26 | AmericanBankingNews.com

    This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law.

    Comment?

  3. NTN Buzztime Inc. (NTN) Lowered to Sell at Zacks Investment ResearchRead the original story w/Photo

    Thursday Aug 25 | AmericanBankingNews.com

    According to Zacks, "NTN Buzztime, Inc.is a leading developer, publisher and distributor of interactive entertainment for massive audiences on numerous consumer platforms. Millions of people are exposed to the Buzztime Network every month in restaurants, sports bars and pubs throughout the U.S., Canada and the UK.

    Comment?

  4. Analysts' Recent Ratings Updates for Ionis PharmaceuticalsRead the original story w/Photo

    Wednesday Aug 24 | AmericanBankingNews.com

    They now have a $46.00 price target on the stock. 8/11/2016 - Ionis Pharmaceuticals had its "hold" rating reaffirmed by analysts at Leerink Swann.

    Comment?

  5. MaxLinear (MXL) - Research Analysts' Weekly Ratings UpdatesRead the original story w/Photo

    Tuesday Aug 23 | AmericanBankingNews.com

    According to Zacks, "MaxLinear is a provider of radio-frequency analog and mixed signal semiconductor SoC solutions for broadband communication applications offering small silicon die-size, and low power consumption. The Company's RF receiver products capture and process digital and analog broadband signals to be decoded for various applications.

    Comment?

  6. NTN Buzztime Inc. (NTN) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    Thursday Aug 18 | AmericanBankingNews.com

    According to Zacks, "NTN Buzztime, Inc.is a leading developer, publisher and distributor of interactive entertainment for massive audiences on numerous consumer platforms. Millions of people are exposed to the Buzztime Network every month in restaurants, sports bars and pubs throughout the U.S., Canada and the UK.

    Comment?

  7. Stock Analysts' Upgrades for August, 18th (BBY, CONE, HVRRY,...Read the original story w/Photo

    Thursday Aug 18 | AmericanBankingNews.com

    Barclays PLC currently has $57.00 price target on the stock, up from their previous price target of $50.00. This story is the sole property of American Banking News and it was originally published by American Banking News.

    Comment?

  8. NTN Buzztime Inc. (NTN) Stock Rating Upgraded by Zacks Investment ResearchRead the original story w/Photo

    Wednesday Aug 17 | AmericanBankingNews.com

    According to Zacks, "NTN Buzztime, Inc.is a leading developer, publisher and distributor of interactive entertainment for massive audiences on numerous consumer platforms. Millions of people are exposed to the Buzztime Network every month in restaurants, sports bars and pubs throughout the U.S., Canada and the UK.

    Comment?

  9. Research Analysts' Recent Ratings Updates for Ionis PharmaceuticalsRead the original story w/Photo

    Sunday Aug 14 | AmericanBankingNews.com

    Several brokerages have updated their recommendations and price targets on shares of Ionis Pharmaceuticals in the last few weeks: 8/11/2016 - Ionis Pharmaceuticals had its "hold" rating reaffirmed by analysts at Leerink Swann. They now have a $36.00 price target on the stock.

    Comment?

  10. Zacks Investment Research Downgrades MaxLinear Inc. (MXL) to HoldRead the original story w/Photo

    Saturday Aug 13 | AmericanBankingNews.com

    According to Zacks, "MaxLinear is a provider of radio-frequency analog and mixed signal semiconductor SoC solutions for broadband communication applications offering small silicon die-size, and low power consumption. The Company's RF receiver products capture and process digital and analog broadband signals to be decoded for various applications.

    Comment?

  11. Zacks Investment Research Lowers MaxLinear Inc. (MXL) to HoldRead the original story w/Photo

    Friday Aug 12 | AmericanBankingNews.com

    According to Zacks, "MaxLinear is a provider of radio-frequency analog and mixed signal semiconductor SoC solutions for broadband communication applications offering small silicon die-size, and low power consumption. The Company's RF receiver products capture and process digital and analog broadband signals to be decoded for various applications.

    Comment?

  12. Analysts' Recent Ratings Changes for MaxLinearRead the original story w/Photo

    Friday Aug 12 | AmericanBankingNews.com

    They now have a "buy" rating on the stock. 8/9/2016 - MaxLinear had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $21.00 price target on the stock.

    Comment?

  13. Ionis Pharmaceuticals Inc. (IONS) Cut to Hold at Zacks Investment ResearchRead the original story w/Photo

    Thursday Aug 11 | AmericanBankingNews.com

    According to Zacks, "Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.

    Comment?

  14. NTN Buzztime Inc. (NTN) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    Sunday Aug 7 | AmericanBankingNews.com

    According to Zacks, "NTN Buzztime, Inc.is a leading developer, publisher and distributor of interactive entertainment for massive audiences on numerous consumer platforms. Millions of people are exposed to the Buzztime Network every month in restaurants, sports bars and pubs throughout the U.S., Canada and the UK.

    Comment?

  15. NTN Buzztime Inc. (NTN) Rating Lowered to Sell at Zacks Investment ResearchRead the original story w/Photo

    Friday Aug 5 | AmericanBankingNews.com

    According to Zacks, "NTN Buzztime, Inc.is a leading developer, publisher and distributor of interactive entertainment for massive audiences on numerous consumer platforms. Millions of people are exposed to the Buzztime Network every month in restaurants, sports bars and pubs throughout the U.S., Canada and the UK.

    Comment?

  16. Ionis Pharmaceuticals Inc. (IONS) Stock Rating Upgraded by Zacks Investment ResearchRead the original story w/Photo

    Wednesday Aug 3 | AmericanBankingNews.com

    According to Zacks, "Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.

    Comment?

  17. Ionis Pharmaceuticals Inc. (IONS) Rating Increased to Hold at Zacks Investment ResearchRead the original story w/Photo

    Wednesday Aug 3 | AmericanBankingNews.com

    According to Zacks, "Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.

    Comment?

  18. Ionis Pharmaceuticals (IONS) - Research Analysts' Weekly Ratings UpdatesRead the original story w/Photo

    Jul 24, 2016 | AmericanBankingNews.com

    They now have a $26.00 price target on the stock, down previously from $39.00. 7/15/2016 - Ionis Pharmaceuticals had its "underperform" rating reaffirmed by analysts at Jefferies Group.

    Comment?

  19. MaxLinear Inc. (MXL) Lifted to "Buy" at Zacks Investment ResearchRead the original story w/Photo

    Jul 23, 2016 | AmericanBankingNews.com

    The firm currently has a $24.00 price objective on the stock. Zacks Investment Research's price objective would indicate a potential upside of 13.74% from the company's previous close.

    Comment?

  20. MaxLinear Inc. (MXL) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    Jul 21, 2016 | AmericanBankingNews.com

    The brokerage currently has a $24.00 target price on the stock. Zacks Investment Research's target price would suggest a potential upside of 12.57% from the company's current price.

    Comment?

Carlsbad Job Listings
View or post Carlsbad job listings on Topix.
Carlsbad Real Estate
News, listings, and foreclosures in Carlsbad from Topix.
Carlsbad Mortgages
Find mortgage rates in Carlsbad on Topix.